Changes of bone turnover markers during perioperative anthracycline- and/or taxane-based chemotherapy in pre- and postmenopausal patients with primary breast cancer

被引：0
|
作者：
Kurbacher, C. M. [1 ]
Rauschenbach, N. [1 ]
Kurbacher, A. T. [1 ]
Sperling, S. [1 ]
Herz, S. [1 ]
Monreal, K. [1 ]
Kurbacher, J. A. [1 ]
机构：
[1] Gynecol Ctr Bonn Friedenspl, Bonn, Nrw, Germany
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.SABCS15-P4-10-17
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P4-10-17
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Chemotherapy Response Assay Test and Prognosis for Breast Cancer Patients Who Have Undergone Anthracycline-and Taxane-Based Chemotherapy
    Lee, Anbok
    Lim, Woosung
    Moon, Byung-In
    Paik, Nam-Sun
    Koh, Suck-Hwan
    Song, Jeong-Yoon
    JOURNAL OF BREAST CANCER, 2011, 14 (04) : 283 - 288
  • [22] African American Women Who Receive Primary Anthracycline- and Taxane-Based Chemotherapy for Triple-Negative Breast Cancer Suffer Worse Outcomes Compared With White Women Reply
    Dawood, Shaheenah
    Gonazalez-Angulo, Ana Maria
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (22) : E38 - E39
  • [23] Body Composition as a Predictor of Toxicity in Patients Receiving Anthracycline and Taxane-Based Chemotherapy for Early-Stage Breast Cancer
    Shachar, Shlomit Strulov
    Deal, Allison M.
    Weinberg, Marc
    Williams, Grant R.
    Nyrop, Kirsten A.
    Popuri, Karteek
    Choi, Seul Ki
    Muss, Hyman B.
    CLINICAL CANCER RESEARCH, 2017, 23 (14) : 3537 - 3543
  • [24] Pathologic Response Rates Following Neoadjuvant Anthracycline and Taxane-based Chemotherapy for Early Breast Cancer (EBC)
    Redana, S.
    Papadimitraki, E.
    Mohammed, K.
    Lote, H.
    Sharp, A.
    Capelan, M.
    CLINICAL ONCOLOGY, 2017, 29 (06) : E103 - E103
  • [25] Effect of once-weekly epoetin beta on survival in patients with metastatic breast cancer receiving anthracycline- and/or taxane-based chemotherapy: Results of the Breast Cancer-Anemia and the Value of Erythropoietin (BRAVE) study
    Aapro, Matti
    Leonard, Robert C.
    Barnadas, Agusti
    Marangolo, Maurizio
    Untch, Michael
    Malamos, Nikolaos
    Mayordomo, Jose
    Reichert, Dietmar
    Luiz Pedrini, Jose
    Ukarma, Lidia
    Scherhag, Armin
    Burger, Hans-Ulrich
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (04) : 592 - 598
  • [26] Reported Bone Pain in Patients with Breast Cancer Receiving Taxane-Based Chemotherapy in Clinical Trials of Pegfilgrastim
    Schwartzberg, L. S.
    Mo, M.
    Harms, R.
    Vogel, C. L.
    CANCER RESEARCH, 2009, 69 (24) : 576S - 576S
  • [27] Associations of age, body mass index, diabetes and hypertension with relative dose intensity among women receiving anthracycline- and/or taxane-based chemotherapy for invasive breast cancer
    Wopat, Heather
    Aldous, Annette
    Ciarleglio, Adam
    Anderson, Kendall
    Robien, Kim
    CANCER RESEARCH, 2024, 84 (09)
  • [28] Muscle and Joint Symptoms in Breast Cancer Patients Receiving Taxane-Based Chemotherapy
    van Draanen, J.
    Stacey, E.
    Dent, R.
    Gallo-Hershberg, D.
    Pasetka, M.
    Giotis, A.
    Kan, K.
    van Draanen, L.
    Fang, T.
    Lee, V.
    Walker, S.
    DeAngelis, C.
    CANCER RESEARCH, 2010, 70
  • [29] Longitudinal changes in patient-reported symptoms and physical function during taxane-based chemotherapy in breast cancer patients.
    Monfort, Scott M.
    Pan, Xueliang Jeff
    Patrick, Robyn
    Singaravelu, Janani
    Layman, Rachel M.
    Mrozek, Ewa
    Ramaswamy, Bhuvaneswari
    Reinbolt, Raquel E.
    Wesolowski, Robert
    Naughton, Michelle Joy
    Shapiro, Charles L.
    Loprinzi, Charles L.
    Chaudhari, Apt M. W.
    Lustberg, Maryam B.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [30] Bone turnover markers in postmenopausal breast cancer patients treated with fulvestrant
    Robertson, J. F. R.
    Agrawal, A.
    Hannon, R. A.
    Cheung, K. L.
    Eastell, R.
    BREAST, 2007, 16 : S53 - S53
12345